Pre-Clinical Equipment Supplied In Austria

Cancer cells have the ability to escape our immune system´s defenses – by outsmarting checkpoint molecules on our immune cells. For more than three decades, science and industry have been working to overcome cancer’s tricky battle ...

Optical transmission, Gas permeability, Biocompatibility, Flexible & Stiff materials, Foils, sheets & plates, Optional: Custom-made formulations & ...

Aposcience AG has identified APO-1 (APOSECTM), derived from the secretome of irradiated, apoptotic peripheral blood mononuclear cells (PBMCs) as superbly efficacious in reducing infarct size and maintaining left ventricular function in animal models of myocardial infarction (MI). These models tested MI with and without reperfusion, including one of ischemia and reperfusion. These data are ...

Aposcience AG has found that the mixture of active components secreted from cultured apoptotic peripheral white blood cells (PBMCs) has superior efficacy in promoting wound healing and skin regeneration. The products have this effect by stimulating migration of keratinocytes and fibroblasts into the wounded area, as well as by promoting neovascularization of the wound and improving blood and ...

Zutectra® is an anti-hepatitis B immunoglobulin for subcutaneous (s.c.) application used for prevention of hepatitis B virus (HBV) re-infection in HBsAg and HBV-DNA negative adult patients at least one week after liver transplantation for hepatitis B induced liver ...

Maintain a needlefree closed system to help minimize exposure to hazardous drugs and comply with USP. Prohibits the escape of hazardous drug or vapor concentrations, Blocks the transfer of environmental contaminants into the system, Eliminates needlestick injuries while minimizing , hazardous drug exposure. With the ChemoLock needlefree CSTD, it has never been easier to keep yourself safe from ...

Our scientific platform includes two distinct approaches to arenavirus-based therapies: replicating and non-replicating. Our replicating technology is designed to create a stronger immune response that we believe is more appropriate for use in oncology. Our non-replicating technology is designed to evoke a potent immune response for prophylactic use against infectious disease. ...

The high level of interferon induced by the delNS vector activates immunological defence reactions against cancer. It also stimulates the production of antiviral ...

The world’s first collaborative robot that treats MSDs with compressed air. For Rehabilitation Centers and Hospitals – Clinics or Sport Clubs. ADAMO is a robotic medical device capable of aiding in the diagnosis of back pain injuries and delivering contactless treatment using temperature-controlled pressurized air. ADAMO can help reduce patient recovery times, waiting lists, and ...

Proper treatment of early stages can significantly reduce the number of heavy cases and hospitalizations. Show2Doc allows virtual care with possibility of full scope outpatient treatment with no visits to the clinic: convenient task manager, simple video calls, timely Live chat, doctors prescriptions, medication management, patient diary, vitals monitoring, scheduling and much more. Daily ...

Chosen more often than any other to provide an effective barrier against bacterial transfer and standardize clinical protocols for all patients and care areas. Help enhance safety and efficiency by choosing industry-leading infection control technology. When you choose ICU Medical needlefree IV sets and connectors with patented Clave™ technology, you get an effective barrier against ...

BRAF encodes a serine/threonine protein kinase, which plays an important role in signaling pathways involved in cell proliferation and differentiation. Determination of BRAF V600 mutational status is recommended in metastatic colorectal cancer (mCRC) at the same time as RAS mutational status for prognostic assessment (and/or potential selection for clinical trials). Testing of patients with ...

NSCLC comprises approximately 85% of all lung cancers. Tumor specimens from patients should be tested for the presence of EGFR mutations prior to TKI treatment. The EGFR XL StripAssay® and EGFR T790M RealFast™ Assay are designed to assist clinicians in the stratification of patients considered for TKI ...

Zinc Oxide Nano- and Non-Nanoparticles (ZnO NPs) are manufactured according to the VERDEQUANT process that substitutes toxic and fossil Ethylene Glycol by bio-based raw materials and guarantees a secure and sustainable route to bio-compatible nano- and ...

The EFIL+ Sirolimus Eluting Stent System is a combination product comprised of two regulated components: a device (a coronary stent system) and a drug product (a formulation of Sirolimus contained in a polymer coating) pre mounted on balloon catheter between two platinum iridium radio opaque marker bands. EFIL+ uses a validated formulation of low dose Sirolimus (1.30µg/mm ) timed to elute ...

We offer a broad palette of prototyping and mass production solutions for your high quality disposables and biochips. Our services include iterative design and rapid prototyping to save your time during up-scaling and mass production. Our broad interdisciplinary expertise enables us to support you from an early development phase until product implementation not only with our engineering expertise ...

PBMCs driven into apoptosis through cellular stress have been shown to be highly potent in experimental wound healing, stroke, spinal cord injury, acute and chronic infarction models and prevention of ischemia reperfusion ...

Momo is a Microbiology Analytics and Clinical Tool for Reporting Pathogens and Antimicrobial ...

The Cryo-Pulse 5 Plus is an electrically powered cryostat for use with HPGe radiation detectors. It utilizes a pulse tube cooler, a highly reliable technology originally used in military and space applications and which has proven its value for germanium detectors in the original Cryo-Pulse 5. Like its predecessor, the Cryo-Pulse 5 Plus still consists of a coldheadassembly, to which the detector ...

A reliable tool to personalize therapy of lung cancer patients with acquired TKI-resistance mutation T790M in the EGFR ...